911O Performance of dual p16 and HPV testing for determining prognosis in cancer of the oropharynx, the EPIC-OPC Study
Hisham Mehanna(University Hospitals Birmingham NHS Foundation Trust), Laia Alemany(Centro de Investigación Biomédica en Red), Andrew Schache(University of Liverpool), Nikolaos Batis(Institut d'Investigació Biomédica de Bellvitge), R.H. Brakenhoff(Cancer Center Amsterdam), M. Mena(Instituto de Salud Carlos III), Jacqueline A. James(Queen's University Belfast), Martina A. Broglie(Kantonsspital St. Gallen), Jens Peter Klußmann(Lungenklinik Köln-Merheim), H. Mirghani(Assistance Publique – Hôpitaux de Paris), Christian von Buchwald(University of Copenhagen), Markus Hoffmann(Christian-Albrechts-Universität zu Kiel), Tina Dalianis(Karolinska University Hospital), M. Taberna Sanz(Institut Català d'Oncologia), Sara Tous(Institut d'Investigació Biomédica de Bellvitge), Jill Brooks(Immune Regulation (United Kingdom)), Shao Hui Huang(University of Toronto), R. Baatenburg de Jong(Erasmus MC Cancer Institute)
Cited by 3
Related Papers
QuPath: Open source software for digital pathology image analysis
|Scientific Reports|2017|8.9k
Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis
|The Lancet|2019|1.3k
QuPath: Open source software for digital pathology image analysis
|bioRxiv (Cold Spring Harbor Laboratory)|2017|809